Table 2 Indications to MR Treatment by MitraClip System
From: Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review
CLINICAL INDICATIONS | CLINICAL CONTRAINDICATIONS | ECHOCARDIOGRAPHIC INDICATIONS | ECHOCARDIOGRAPHIC CONTRAINDICATIONS |
|---|---|---|---|
MR 3+ or 4+ and Symptoms or/and New Atrial Fibrillation | Recent Myocardial Infarction Recent Surgical Procedure Renal Insufficiency Endocarditis Rheumatic Heart Disease | MR 3+ or 4+ Compromised Left Ventricular Function (EF < 60% or End-Systolic Diameter ≥ 40 mm) Pulmonary Hypertension A Regurgitant Jet Origin at Level of Coaptation Zone Coaptation Length ≥ 2 mm Coaptation Depth ≤ 11 mm Flail Gap < 10 mm Flail Width < 15 mm | Left Ventricular EF < 25% Left Ventricular End-Systolic Diameter > 55 mm Mitral Valve Orifice Area < 4 cm2 |